PRPO

Precipio, Inc. develops and commercializes proprietary hematopathology diagnostic products and services aimed at improving the accuracy and efficiency of blood cancer diagnostics. The company offers molecular kits for detecting mutations related to various blood cancers, as well as clinical hematopathology services. Precipio operates a clinical laboratory that leverages advanced technologies and expertise to deliver precise diagnostic results to healthcare providers and patients, serving a global market through a network of distribution partners.